Novavax, Inc.
CH ˙ SWX ˙ US6700024010
SecurityCH:NVAX / Novavax, Inc.
InstitutionQuantbot Technologies LP
Latest Disclosed Ownership13,298 shares
Latest Disclosed Value $ 108,246
Quantbot Technologies LP reports 7,815.48% increase in ownership of NVAX / Novavax, Inc.

On May 13, 2026 - Quantbot Technologies LP filed a 13F-HR form disclosing ownership of 13,298 shares of Novavax, Inc. (CH:NVAX) valued at $108,246 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 168 shares of Novavax, Inc.. This represents a change in shares of 7,815.48% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NOVAVAX COM 670002401 13,298 13,130 7,815.48 108 10,700.00 0.0044
2026-02-10 2025-12-31 13F NOVAVAX COM 670002401 168 168 1 0.0000
2023-08-08 2023-06-30 13F NOVAVAX COM 670002401 0 -67,600 -100.00 0 -100.00
2023-05-12 2023-03-31 13F NOVAVAX COM 670002401 67,600 49,600 275.56 468 152.97 0.0332
2023-02-13 2022-12-31 13F NOVAVAX COM 670002401 18,000 18,000 185 0.0133
2022-02-11 2021-12-31 13F NOVAVAX COM 670002401 0 -2,115 -100.00 0 -100.00
2021-11-09 2021-09-30 13F NOVAVAX COM 670002401 2,115 1,578 293.85 438 284.21 0.0320
2021-08-12 2021-06-30 13F NOVAVAX COM 670002401 537 315 141.89 114 185.00 0.0090
2021-05-14 2021-03-31 13F NOVAVAX COM 670002401 222 222 -58.66 40 -64.91 0.0038
2020-11-16 2020-09-30 13F NOVAVAX COM 670002401 0 -4,432 -100.00 0 -100.00
2020-08-13 2020-06-30 13F NOVAVAX COM 670002401 4,432 4,432 369 0.0488
2017-05-10 2017-03-31 13F NOVAVAX COM 670002104 0 -462,250 -100.00 0 -100.00
2017-02-09 2016-12-31 13F NOVAVAX COM 670002104 462,250 462,250 582 0.0645
2016-04-28 2016-03-31 13F NOVAVAX COM 670002104 0 0 0 0.0000
2016-01-22 2015-12-31 13F NOVAVAX COM 670002104 0 -26,588 -100.00 0 -100.00
2015-10-22 2015-09-30 13F NOVAVAX COM 670002104 26,588 26,588 187 0.0326
2015-07-27 2015-06-30 13F NOVAVAX COM 670002104 0 -13,445 -100.00 0 -100.00
2015-04-24 2015-03-31 13F NOVAVAX COM 670002104 13,445 13,445 111 0.0275
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.